Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Novavax extends option agreement with Cantab

July 29, 1998

Scientists report success in achieving tolerance in transplantation models

July 22, 1998

Lisofylline development timetable readjusted, marketing agreements revised

July 22, 1998

Promising phase II results reported for BTI-322 in GVHD

July 21, 1998

Ribi acquires new adjuvant technology from U of Nebraska

July 21, 1998

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

July 17, 1998

Clinical evaluation of AlloMune transplantation system begins

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...